RxDoctor Payments Data

Amanda Davis, PA

Medical · Oak Hill, WVNPI 1538433271

Payments from drug & device makers

$2,103in general payments, 2019–2025

Across 130 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$142
  • Abbott$103
  • Novartis$34
  • Aimmune Therapeutics, Inc.$26
  • GSK$22
  • plus $95 from 6 others

What the payments were for

  • Food & beverage$2,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,103 in reported general payments places this provider in the 70th percentile of 233 medical providers in West Virginia.

See all medical providers in West Virginia

Medicare billing

Part B allowed, 2024
$2,409
Medicare patients
80
Services billed
122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide108$113,588
EliquisApixaban73$98,013
MounjaroTirzepatide78$90,941
TrulicityDulaglutide81$88,462
JanuviaSitagliptin Phosphate47$58,910
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$57,858
EntrestoSacubitril/Valsartan22$34,653
JardianceEmpagliflozin18$27,099
Tresiba Flextouch U-100Insulin Degludec16$21,433
Breo ElliptaFluticasone/Vilanterol31$17,262
Lantus SolostarInsulin Glargine,hum.Rec.Anlog101$17,023
LinzessLinaclotide14$14,553
MyrbetriqMirabegron14$11,597
Advair HfaFluticasone Propion/Salmeterol18$8,783
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$14$113,588108 claims
PfizerEliquis$142$98,01373 claims
GSKTrelegy Ellipta, Breo Ellipta$22$75,11985 claims
NovartisEntresto$34$34,65322 claims
AbbVieLinzess, Synthroid$1,681$17,31357 claims
AstraZenecaBreztri Aerosphere, Symbicort$14$13,39232 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 233 medical providers in West Virginia.

Other medical in Oak Hill

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →